Annual Shareholders Equity
-$127.70 K
-$11.47 M-101.13%
December 31, 2023
Summary
- As of February 7, 2025, ATNF annual stockholders equity is -$127.70 thousand, with the most recent change of -$11.47 million (-101.13%) on December 31, 2023.
- During the last 3 years, ATNF annual shareholders equity has fallen by -$30.41 million (-100.42%).
- ATNF annual shareholders equity is now -100.32% below its all-time high of $39.32 million, reached on December 31, 2021.
Performance
ATNF Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$3.73 M
+$4.15 M+993.25%
September 30, 2024
Summary
- As of February 7, 2025, ATNF quarterly stockholders equity is $3.73 million, with the most recent change of +$4.15 million (+993.25%) on September 30, 2024.
- Over the past year, ATNF quarterly shareholders equity has increased by +$4.69 million (+491.18%).
- ATNF quarterly shareholders equity is now -91.27% below its all-time high of $42.79 million, reached on June 30, 2022.
Performance
ATNF Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ATNF Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -101.1% | +491.2% |
| 3 y3 years | -100.4% | -47.7% |
| 5 y5 years | -100.3% | -47.7% |
ATNF Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.3% | at low | -91.3% | +491.2% |
| 5 y | 5-year | -100.3% | at low | -91.3% | +491.2% |
| alltime | all time | -100.3% | at low | -91.3% | +491.2% |
180 Life Sciences Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.73 M(-993.3%) |
| Jun 2024 | - | -$418.00 K(-56.2%) |
| Mar 2024 | - | -$954.50 K(+647.5%) |
| Dec 2023 | -$127.70 K(-101.1%) | -$127.70 K(-14.5%) |
| Sep 2023 | - | -$149.30 K(-102.2%) |
| Jun 2023 | - | $6.72 M(-5.9%) |
| Mar 2023 | - | $7.14 M(-37.1%) |
| Dec 2022 | $11.34 M | $11.34 M(-56.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $26.08 M(-39.1%) |
| Jun 2022 | - | $42.79 M(+4.6%) |
| Mar 2022 | - | $40.90 M(+4.0%) |
| Dec 2021 | $39.32 M(+29.8%) | $39.32 M(+5.9%) |
| Sep 2021 | - | $37.14 M(+1267.4%) |
| Jun 2021 | - | $2.72 M(-88.0%) |
| Mar 2021 | - | $22.71 M(-25.0%) |
| Dec 2020 | $30.29 M(-21.5%) | $30.29 M(-21.5%) |
| Dec 2019 | $38.57 M | $38.57 M |
FAQ
- What is 180 Life Sciences annual stockholders equity?
- What is the all time high annual shareholders equity for 180 Life Sciences?
- What is 180 Life Sciences annual shareholders equity year-on-year change?
- What is 180 Life Sciences quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for 180 Life Sciences?
- What is 180 Life Sciences quarterly shareholders equity year-on-year change?
What is 180 Life Sciences annual stockholders equity?
The current annual shareholders equity of ATNF is -$127.70 K
What is the all time high annual shareholders equity for 180 Life Sciences?
180 Life Sciences all-time high annual stockholders equity is $39.32 M
What is 180 Life Sciences annual shareholders equity year-on-year change?
Over the past year, ATNF annual stockholders equity has changed by -$11.47 M (-101.13%)
What is 180 Life Sciences quarterly stockholders equity?
The current quarterly shareholders equity of ATNF is $3.73 M
What is the all time high quarterly shareholders equity for 180 Life Sciences?
180 Life Sciences all-time high quarterly stockholders equity is $42.79 M
What is 180 Life Sciences quarterly shareholders equity year-on-year change?
Over the past year, ATNF quarterly stockholders equity has changed by +$4.69 M (+491.18%)